Loading insider details...
Beta
Latest Form 4 (Jul 1, 2026): Grant/Award of 31,667 AUTL shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 1, 2026 | Autolus Therapeutics plc (AUTL) | Grant/Award | 31,667 | n/a |
| Jun 12, 2026 | Praxis Precision Medicines, Inc. (PRAX) | Grant/Award | 1,371 | n/a |
| Jun 27, 2025 | Praxis Precision Medicines, Inc. (PRAX) | Grant/Award | 10,520 | n/a |
| Jun 6, 2024 | Praxis Precision Medicines, Inc. (PRAX) | Grant/Award | 8,566 | n/a |
| Jun 14, 2023 | Praxis Precision Medicines, Inc. (PRAX) | Grant/Award | 28,981 | n/a |
| May 27, 2022 | Praxis Precision Medicines, Inc. (PRAX) | Grant/Award | 22,753 | n/a |
| Apr 29, 2022 | Theravance Biopharma, Inc. (TBPH) | Grant/Award | 9,852 | n/a |
| Jul 7, 2021 | Praxis Precision Medicines, Inc. (PRAX) | Other (see footnotes) | 28,473 | n/a |
| Jun 9, 2021 | Praxis Precision Medicines, Inc. (PRAX) | Grant/Award | 22,343 | n/a |
| Apr 29, 2021 | Theravance Biopharma, Inc. (TBPH) | Grant/Award | 9,828 | n/a |